Molecularly
imprinted polymers studied. A class of molecularly imprinted polymers (MIPs)
can bind to small organic molecules as readily as—or more readily than—natural
antibodies. MIPs are effective at lower concentrations than their natural counterparts,
and the polymers display potential for greater stability, lower cost, and more
customized manufacture than has previously been possible, according to Semorex
Inc. (Jerusalem, Israel; +972 8 9725539). The company's MIPs comprise a proprietary
combination of functional monomers and other components. During MIP synthesis,
the polymers are imprinted to match the size, shape, charge, and functional
groups of the target molecules by using the molecules themselves as a template.
Development of MIPs is expected to facilitate new treatments for heart disease
and cancers.